Activation of SGK1/NF- κ B pathway is correlated with low sensitivity to proteasome inhibitors in multiple myeloma Cells

被引：0
|
作者：
Kimura, Akihiro [1 ]
Tsubaki, Masanobu [1 ]
Takeda, Tomoya [1 ]
Matsuda, Takuya [1 ]
Takefuji, Honoka [1 ]
Nishida, Shozo [1 ]
机构：
[1] Kindai Univ, Dept Pharmacotherapy, Fac Pharm, Higashiosaka, Osaka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3318
引用
收藏
页码：1989 / 1989
页数：1
相关论文
共 50 条
  • [21] NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
    Conticello, Concetta
    Giuffrida, Raffaella
    Adamo, Luana
    Anastasi, Gabriele
    Martinetti, Daniela
    Salomone, Edvige
    Colarossi, Cristina
    Amato, Gabriella
    Gorgone, Ausilia
    Romano, Alessandra
    Iannolo, Gioacchin
    De Maria, Ruggero
    Giustolisi, Rosario
    Gulisano, Massimo
    Di Raimondo, Francesco
    LEUKEMIA RESEARCH, 2011, 35 (01) : 52 - 60
  • [22] Eriocalyxin B selectively inhibits NF-κB activity by targeting multiple steps of the NF-κB activation pathway
    Leung, Chung-Hang
    Grill, Susan P.
    Lam, Wing
    Sun, Han-Dong
    Cheng, Yung-Chi
    CANCER RESEARCH, 2006, 66 (08)
  • [23] Proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma cells to chemotherapeutic agents and overcomes chemo-resistance through inhibition of the NF-κB pathway.
    Ma, MH
    Parker, KM
    Manyak, S
    Altamirano, CV
    Wu, ZQ
    Borad, MJ
    Roussos, E
    Neeser, J
    Mikail, A
    Frantzen, M
    Adams, J
    Yang, H
    Siak-Shie, N
    Vescio, RA
    Berenson, JR
    BLOOD, 2001, 98 (11) : 473A - 473A
  • [24] Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway
    Gao, Hui
    Wang, Jianrong
    MOLECULAR MEDICINE REPORTS, 2016, 13 (02) : 1827 - 1832
  • [25] LGR4 promotes proliferation and homing via activation of the NF-κB signaling pathway in multiple myeloma
    He, Nihan
    Yang, Qin
    Li, Zhengjiang
    Guo, Jiaojiao
    Kuang, Chunmei
    Zhu, Yinghong
    Liu, Xing
    Chen, Xun
    Shi, Fangming
    Feng, Xiangling
    An, Gang
    Zhang, Guoping
    Zhou, Wen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2025, 66 (02)
  • [26] Effect of proteasome inhibitors on monocytic IκB-α and -β depletion, NF-κB activation, and cytokine production
    Haas, M
    Page, S
    Page, M
    Neumann, FJ
    Marx, N
    Adam, M
    Ziegler-Heitbrock, HWL
    Neumeier, D
    Brand, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (03) : 395 - 404
  • [27] Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
    Li Yang
    Jing Chen
    Xiaoyan Han
    Enfan Zhang
    Xi Huang
    Xing Guo
    Qingxiao Chen
    Wenjun Wu
    Gaofeng Zheng
    Donghua He
    Yi Zhao
    Yang Yang
    Jingsong He
    Zhen Cai
    Protein & Cell, 2018, 9 (09) : 770 - 784
  • [28] Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
    Yang, Li
    Chen, Jing
    Han, Xiaoyan
    Zhang, Enfan
    Huang, Xi
    Guo, Xing
    Chen, Qingxiao
    Wu, Wenjun
    Zheng, Gaofeng
    He, Donghua
    Zhao, Yi
    Yang, Yang
    He, Jingsong
    Cai, Zhen
    PROTEIN & CELL, 2018, 9 (09) : 770 - 784
  • [29] NF-κB PATHWAY ACTIVATION DETERMINES DRUG SENSITIVITY IN MANTLE CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2014, 4 (02) : 144 - 144
  • [30] Alkylating agents induce activation of NFκB in multiple myeloma cells
    Baumann, Philipp
    Mandl-Weber, Sonja
    Oduncu, Fuat
    Schmidmaier, Ralf
    LEUKEMIA RESEARCH, 2008, 32 (07) : 1144 - 1147
12345